These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The changing landscape of cancer drug discovery: a challenge to the medicinal chemist of tomorrow. Pors K; Goldberg FW; Leamon CP; Rigby AC; Snyder SA; Falconer RA Drug Discov Today; 2009 Nov; 14(21-22):1045-50. PubMed ID: 19638319 [TBL] [Abstract][Full Text] [Related]
4. Trends in immunoconjugate and ligand-receptor based targeting development for cancer therapy. Brumlik MJ; Daniel BJ; Waehler R; Curiel DT; Giles FJ; Curiel TJ Expert Opin Drug Deliv; 2008 Jan; 5(1):87-103. PubMed ID: 18095930 [TBL] [Abstract][Full Text] [Related]
5. Challenges in the development and manufacturing of antibody-drug conjugates. Ducry L Methods Mol Biol; 2012; 899():489-97. PubMed ID: 22735971 [TBL] [Abstract][Full Text] [Related]
9. The oncology market for antibody-drug conjugates. do Pazo C; Nawaz K; Webster RM Nat Rev Drug Discov; 2021 Aug; 20(8):583-584. PubMed ID: 33762691 [No Abstract] [Full Text] [Related]
10. Seattle Genetics announces collaboration with Oxford BioTherapeutics. Sutton C Future Med Chem; 2011 Nov; 3(15):1860. PubMed ID: 22132448 [No Abstract] [Full Text] [Related]
11. There is no better time than the present: nanotechnology as a disruptive innovation for drug development. Oo C; Tsai JC; Kao HD Drug Discov Today; 2015 Jun; 20(6):645-7. PubMed ID: 25835226 [No Abstract] [Full Text] [Related]
12. Bioanalysis special focus issue on antibody-drug conjugates. Kaur S Bioanalysis; 2013 May; 5(9):981-3. PubMed ID: 23641688 [No Abstract] [Full Text] [Related]
13. The antibody-drug conjugate: an enabling modality for natural product-based cancer therapeutics. Gerber HP; Koehn FE; Abraham RT Nat Prod Rep; 2013 May; 30(5):625-39. PubMed ID: 23525375 [TBL] [Abstract][Full Text] [Related]
17. NCI seeks to speed drug development for pediatric cancers: New initiative aims to help prioritize agents with most potential. Printz C Cancer; 2016 Feb; 122(4):499-500. PubMed ID: 26844936 [No Abstract] [Full Text] [Related]
18. Algeta and Ablynx collaborate to discover and develop targeted cancer therapies. King G Future Med Chem; 2013 Feb; 5(2):123. PubMed ID: 23476969 [No Abstract] [Full Text] [Related]
19. Anticancer drug discovery in the future: an evolutionary perspective. Ma X; Wang Z Drug Discov Today; 2009 Dec; 14(23-24):1136-42. PubMed ID: 19800414 [TBL] [Abstract][Full Text] [Related]
20. Anticancer drug development: moving away from the old habits. Ades F; Zardavas D; Aftimos P; Awada A Curr Opin Oncol; 2014 May; 26(3):334-9. PubMed ID: 24614094 [No Abstract] [Full Text] [Related] [Next] [New Search]